I am pleased to announce that we (Mark S. Butler, Ian R. Henderson, Robert J. Capon and Mark A. T. Blaskovich) have been awarded the 2024 Journal of Antibiotics Ōmura Award for Reviews’ Medal for the review “Antibiotics in the clinical pipeline as of December 2022”.
It is an honour to receive an award named after Prof. Satoshi Ōmura, the 2015 Nobel Laureate and Japanese microbiologist renowned for his discovery of avermectins, which led to the development of ivermectin—a breakthrough that has transformed global health by combating parasitic diseases such as river blindness and lymphatic filariasis. His pioneering work at Kitasato University, Tokyo, exemplifies the power of natural product research in saving millions of lives.
